Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy
| Image |  |
|---|---|
| Description | scientific article published on 12 February 2012 |
| Author/s |
author: Ursula A. Matulonis Colleen Feltmate |
| Publication date | February 12, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |